Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma

c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma

(2013) Lei Wang et al.   HEPATOLOGY

MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity

(2013) Leibo Xu et al.   JOURNAL OF HEPATOLOGY

The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells

(2012) Toshihiko Sakurai et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A

(2012) Xufu Wei et al.   CELLULAR SIGNALLING

MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma

(2012) Yanqiong Zhang et al.   FEBS LETTERS

Loss ofmiR-101expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells

(2012) Antonio Strillacci et al.   JOURNAL OF PATHOLOGY

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

(2012) Angela M Liu et al.   BMJ Open

Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma

(2011) Jin Hou et al.   CANCER CELL

Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma

(2011) Yoshito Tomimaru et al.   JOURNAL OF HEPATOLOGY

miR-101 DNA Copy Loss is a Prominent Subtype Specific Event in Lung Cancer

(2011) Kelsie L. Thu et al.   Journal of Thoracic Oncology

Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection

(2011) Beom Kyung Kim et al.   ONCOLOGY

MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21waf1/cip1

(2011) Assaad Semaan et al.   PHARMACEUTICAL RESEARCH

MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels

(2011) Lena M. Wulfken et al.   PLoS One

Serum microRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV-Positive Hepatocarcinoma

(2010) L.-M. Li et al.   CANCER RESEARCH

Dysregulation of microRNAs in cancer: Playing with fire

(2010) Sonia A. Melo et al.   FEBS LETTERS

Hepatocellular carcinoma: diagnostics and screening

(2010) Madhvi Patel et al.   JOURNAL OF EVALUATION IN CLINICAL PRACTICE

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β

(2010) Paul Cao et al.   Molecular Cancer

Export of microRNAs and microRNA-protective protein by mammalian cells

(2010) Kai Wang et al.   NUCLEIC ACIDS RESEARCH

MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity

(2009) H. Su et al.   CANCER RESEARCH

Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients

(2009) Masami Tanaka et al.   PLoS One

miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells

(2009) Xia Wu et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma

(2008) Shuai Li et al.   HEPATOLOGY

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA